These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 7660619)
21. Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness. Bizanov G; Janakova L; Knapstad SE; Karlstad T; Bakke H; Haugen IL; Haugan A; Samdal HH; Haneberg B Scand J Immunol; 2005 Jun; 61(6):503-10. PubMed ID: 15963044 [TBL] [Abstract][Full Text] [Related]
22. [Reproductive activity of the influenza A virus in the splenocytes of experimental animals with mono- and mixed infections]. Taros LIu; Dubrovina TIa; Beznishchenko IN; Leont'eva GF Vopr Virusol; 1986; 31(4):420-5. PubMed ID: 3765566 [TBL] [Abstract][Full Text] [Related]
23. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Fan J; Liang X; Horton MS; Perry HC; Citron MP; Heidecker GJ; Fu TM; Joyce J; Przysiecki CT; Keller PM; Garsky VM; Ionescu R; Rippeon Y; Shi L; Chastain MA; Condra JH; Davies ME; Liao J; Emini EA; Shiver JW Vaccine; 2004 Aug; 22(23-24):2993-3003. PubMed ID: 15297047 [TBL] [Abstract][Full Text] [Related]
25. Nationwide serological survey of equine influenza in Nigeria. Adeyefa CA; Hamblin C; Cullinane AA; McCauley JW Rev Elev Med Vet Pays Trop; 1996; 49(1):24-7. PubMed ID: 8881415 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of a virus derived from MDCK cells infected persistently with influenza A virus as a potential live-attenuated vaccine candidate in the mouse model. Liu B; Hossain MJ; Mori I; Kimura Y J Med Virol; 2008 May; 80(5):888-94. PubMed ID: 18360902 [TBL] [Abstract][Full Text] [Related]
27. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model. Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783 [TBL] [Abstract][Full Text] [Related]
28. Contact infection of mink with 5 subtypes of avian influenza virus. Brief report. Okazaki K; Yanagawa R; Kida H Arch Virol; 1983; 77(2-4):265-9. PubMed ID: 6314940 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice. Epstein SL; Lo CY; Misplon JA; Lawson CM; Hendrickson BA; Max EE; Subbarao K J Immunol; 1997 Feb; 158(3):1222-30. PubMed ID: 9013963 [TBL] [Abstract][Full Text] [Related]
30. [Comparative study of experimental streptococcal, influenzal and mixed infections]. Loziuk LV; Volos OP Mikrobiol Zh; 1977; 39(4):458-61. PubMed ID: 333242 [No Abstract] [Full Text] [Related]
31. TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization. Marshall D; Sealy R; Sangster M; Coleclough C J Immunol; 1999 Nov; 163(9):4673-82. PubMed ID: 10528164 [TBL] [Abstract][Full Text] [Related]
32. Detection of antibodies to influenza A virus in cattle in association with respiratory disease and reduced milk yield. Brown IH; Crawshaw TR; Harris PA; Alexander DJ Vet Rec; 1998 Dec; 143(23):637-8. PubMed ID: 9881443 [No Abstract] [Full Text] [Related]
33. [Fluorometric determination of the quality of FITC-anti influenza conjugates (author's transl)]. Körting HJ; Klagge E; Herrmann H; Herrmann B; Brunnemann H; Vogt KH; Hartmann M Acta Histochem; 1977; 59(2):258-63. PubMed ID: 412390 [TBL] [Abstract][Full Text] [Related]
34. [Antiviral effect of recombinant antibody to influenza virus HA antigen]. Yang G; Wang Y; Zhao X; Han F; Wu S; Hou Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):337-40. PubMed ID: 12665899 [TBL] [Abstract][Full Text] [Related]
35. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942 [TBL] [Abstract][Full Text] [Related]
36. Efforts to pre-empt an equine influenza epidemic. Mumford J; Cardwell J; Daly J; Newton R Vet Rec; 2003 Mar; 152(13):405-6. PubMed ID: 12696710 [No Abstract] [Full Text] [Related]
37. Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection. Quan FS; Compans RW; Cho YK; Kang SM Vaccine; 2007 Jan; 25(2):272-82. PubMed ID: 16945454 [TBL] [Abstract][Full Text] [Related]
38. The spread and persistence of influenza viruses in normal and cyclophosphamide-treated mice. Abou-Donia H; Jennings R; Potter CW J Med Virol; 1981; 7(4):251-62. PubMed ID: 7334358 [TBL] [Abstract][Full Text] [Related]
39. Equine influenza vaccine performance: still learning lessons from the field. Newton JR Vet J; 2001 Mar; 161(2):107-9. PubMed ID: 11243681 [No Abstract] [Full Text] [Related]
40. Local IL-4 expression in the lung reduces pulmonary influenza-virus-specific secondary cytotoxic T cell responses. Bot A; Holz A; Christen U; Wolfe T; Temann A; Flavell R; von Herrath M Virology; 2000 Mar; 269(1):66-77. PubMed ID: 10725199 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]